rTMS Using Summation of Electromagnetic Fields from a Two-coil Array: Efficacy for Treatment Resistant Major Depressive Disorder

被引：0
|
作者：
Carpenter, Linda [1 ]
Aaronson, Scott [1 ]
Clarke, Gregory [1 ]
Holtzheimer, Paul [1 ]
Johnson, Clark [1 ]
McDonald, William [1 ]
Stannard, Elizabeth [1 ]
Schneider, M. Bret [1 ]
机构：
[1] Butler Hosp, Brown Med Sch, Providence, RI 02906 USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2014年 / 39卷
关键词：
rTMS; depression; stimulation; treatment resistant;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T112
引用
收藏
页码：S365 / S366
页数：2
相关论文
共 50 条
  • [41] Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta-analysis of randomized sham-controlled trials
    Róbert György Vida
    Eszter Sághy
    Richárd Bella
    Sándor Kovács
    Dalma Erdősi
    Judit Józwiak-Hagymásy
    Antal Zemplényi
    Tamás Tényi
    Péter Osváth
    Viktor Voros
    BMC Psychiatry, 23
  • [42] Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies
    Thase, Michael E.
    DIALOGUES IN CLINICAL NEUROSCIENCE, 2014, 16 (04) : 539 - 544
  • [43] Efficacy and acceptability of next step treatment strategies in adults with treatment-resistant major depressive disorder: protocol for systematic review and network meta-analysis
    Muit, Jan Jacobus
    van Eijndhoven, Philip F. P.
    Cipriani, Andrea
    Dalhuisen, Iris
    van Bronswijk, Suzanne
    Furukawa, Toshi A.
    Ruhe, Henricus G.
    BMJ OPEN, 2022, 12 (04):
  • [44] Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder
    Elizabeth Brunner
    Mauricio Tohen
    Olawale Osuntokun
    John Landry
    Michael E Thase
    Neuropsychopharmacology, 2014, 39 : 2549 - 2559
  • [45] Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder
    Brunner, Elizabeth
    Tohen, Mauricio
    Osuntokun, Olawale
    Landry, John
    Thase, Michael E.
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 (11) : 2549 - 2559
  • [46] The role of sex and age in the differential efficacy of 10 Hz and intermittent theta-burst (iTBS) repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD)
    Slan, Aaron R.
    Citrenbaum, Cole
    Corlier, Juliana
    Ngo, Doan
    Vince-Cruz, Nikita
    Jackson, Nicholas J.
    Valles, Thomas E.
    Wilke, Scott A.
    Hoftman, Gil D.
    Koek, Ralph J.
    Leuchter, Michael K.
    Krantz, David E.
    Strouse, Thomas B.
    Tadayonnejad, Reza
    Ginder, Nathaniel D.
    Distler, Margaret G.
    Lee, John H.
    Adelekun, Adesewa E.
    Einstein, Evan H.
    Oughli, Hanadi A.
    Leuchter, Andrew F.
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 366 : 106 - 112
  • [47] Efficacy and safety of brexpiprazole (OPC-34712) as adjunctive treatment in major depressive disorder: Meta-analysis of two pivotal studies
    Eriksson, Hans
    Weiller, Emmanuelle
    Weiss, Catherine
    Zhang, Peter
    Skuban, Aleksandar
    Thase, Michael E.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 102 - 102
  • [48] Deep brain stimulation for treatment-resistant major depressive disorder: a comparison of two targets and long-term follow-up
    Raymaekers, S.
    Luyten, L.
    Bervoets, C.
    Gabriels, L.
    Nuttin, B.
    TRANSLATIONAL PSYCHIATRY, 2017, 7 : e1251 - e1251
  • [49] Deep brain stimulation for treatment-resistant major depressive disorder: a comparison of two targets and long-term follow-up
    S Raymaekers
    L Luyten
    C Bervoets
    L Gabriëls
    B Nuttin
    Translational Psychiatry, 2017, 7 : e1251 - e1251
  • [50] Efficacy of vortioxetine versus desvenlafaxine in the treatment of functional impairment in patients with major depressive disorder: Results from the multinational VIVRE study
    Christensen, Michael Cronquist
    Grande, Iria
    Rieckmann, Andreas
    Chokka, Pratap
    CNS SPECTRUMS, 2024, 29 (05) : 423 - 432
12345